Detalles de la búsqueda
1.
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Cancer
; 129(4): 569-579, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541017
2.
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
BMC Cancer
; 23(1): 193, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849920
3.
Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.
J Biol Chem
; 293(47): 18218-18229, 2018 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262665
4.
Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst.
J Biol Chem
; 290(7): 3894-909, 2015 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25538234
5.
Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells.
Cytotherapy
; 17(5): 579-92, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559145
6.
Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis.
Development
; 138(2): 303-15, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21177343
7.
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.
Front Cell Infect Microbiol
; 14: 1336619, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38415009
8.
The blockade of neuropeptide FF receptor 1 and 2 differentially contributed to the modulating effects on fentanyl-induced analgesia and hyperalgesia in mice.
Eur J Pharmacol
; 969: 176457, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395375
9.
Structure-Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity.
J Med Chem
; 67(1): 272-288, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38118143
10.
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents.
Proc Natl Acad Sci U S A
; 107(10): 4573-8, 2010 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20167798
11.
Development of Pilomatrixoma at the Vaccination Site: A Rare Complication of COVID-19 Vaccination - A Case Report.
Am J Case Rep
; 24: e942280, 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055654
12.
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1157-1167, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37497428
13.
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus.
Front Pharmacol
; 14: 1223632, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37799969
14.
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Int Immunopharmacol
; 115: 109687, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628893
15.
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study.
J Cancer Res Clin Oncol
; 149(16): 14761-14774, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589925
16.
Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
Front Pharmacol
; 14: 1210835, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37456741
17.
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma.
Front Pharmacol
; 14: 1234342, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731737
18.
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1849-1859, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881221
19.
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Int Immunopharmacol
; 115: 109651, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638663
20.
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
J Gastroenterol
; 58(4): 413-424, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894804